THEMISJuly 6, 2024GRAND 306July 6, 2024 This study is being carried out to see if a new drug called ticagrelor given twice daily in addition to the ASA therapy decreases the frequency of cardiovascular events (e.g., death from heart disease, heart attack, or stroke). Read Study Share